アフターアワーズ： 7.73

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT) 最新ニュース

Xbiotech Inc (XBIT)

Xbiotech Inc (XBIT) 最新ニュース

Bank of New York Mellon Corp Buys 49,863 Shares of XBiotech Inc. (NASDAQ:XBIT) - Defense World

XBiotech (NASDAQ:XBIT) vs. Harmony Biosciences (NASDAQ:HRMY) Financial Contrast - Defense World

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.63 - Defense World

XBiotech (NASDAQ:XBIT) Stock Price Passes Above 50-Day Moving Average of $6.63 - MarketBeat

Objective long/short (XBIT) Report - Stock Traders Daily

XBiotech (NASDAQ:XBIT) Shares Pass Above 50-Day Moving Average of $6.47 - MarketBeat

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.47 - Defense World

Is XBiotech (NASDAQ:XBIT) Weighed On By Its Debt Load? - Simply Wall St

Hidradenitis Suppurativa Market Demand, Share, Size, Trends, Forecast To 2033 - WhaTech

Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - GlobeNewswire Inc.

XBiotech Inc. (NASDAQ:XBIT) Stock Holdings Increased by Vanguard Group Inc. - Defense World

XBiotech (NASDAQ:XBIT) Stock Crosses Above Fifty Day Moving Average of $6.22 - MarketBeat

XBiotech (NASDAQ:XBIT) Shares Pass Above 50 Day Moving Average of $6.22 - Defense World

XBiotech: Q2 Earnings Snapshot - CT Insider

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - InvestorPlace

XBiotech: Q2 Earnings Snapshot - San Antonio Express-News

XBIT Stock Earnings: XBiotech Reported Results for Q2 2024 - TradingView

XBiotech: Q2 Earnings Snapshot - The Washington Post

XBiotech: Q2 Earnings Snapshot - The Advocate

XBiotech: Q2 Earnings Snapshot - Danbury News Times

XBiotech: Q2 Earnings Snapshot - CTPost

XBiotech: Q2 Earnings Snapshot - Jacksonville Daily Progress

(XBIT) Trading Signals - Stock Traders Daily

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50 Day Moving Average of $6.35 - Defense World

XBiotech Inc. (NASDAQ:XBIT) most popular amongst retail investors who own 51%, insiders hold 35% - Yahoo Finance

XBiotech (NASDAQ:XBIT) Stock Crosses Above 50-Day Moving Average of $6.35 - MarketBeat

(XBIT) Investment Analysis - Stock Traders Daily

XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - MarketBeat

XBiotech Inc. (NASDAQ:XBIT) Sees Significant Increase in Short Interest - Defense World

XBiotech Inc. (NASDAQ:XBIT) Shares Acquired by Empowered Funds LLC - Defense World

XBiotech Inc. (NASDAQ:XBIT) Sees Large Decrease in Short Interest - Defense World

XBiotech Inc. (NASDAQ:XBIT) Short Interest Update - MarketBeat

Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key CompaniesFibroGen, OSE Immunotherapeutics, Panbela Therapeutics, Lokon Pharma, Helix Biopharma, Tvardi Therapeutics, BioNTech, XBiotech, Lumicell, CARsgen Ther - Yahoo Finance

Long Term Trading Analysis for (XBIT) - Stock Traders Daily

XBiotech Inc. (NASDAQ:XBIT) surges 26%; individual investors who own 51% shares profited along with insiders - Simply Wall St

XBiotech (NASDAQ:XBIT) Shares Pass Below 50-Day Moving Average of $7.29 - MarketBeat

XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50 Day Moving Average of $7.29 - Defense World

XBiotech Inc (XBIT) Stock: Navigating a Year of Volatility - The InvestChronicle

Analyzing Ratios: XBiotech Inc (XBIT)'s Financial Story Unveiled – DWinneX - The Dwinnex

Vertus Energy raises €8.75M Seed for Waste-to-X biotech solutions - Tech.eu

What Kind Of Investor Owns Most Of XBiotech Inc. (NASDAQ:XBIT)? - Yahoo New Zealand News

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? - MSN

The Psychology of XBiotech Inc Inc. (XBIT) Price Performance: Understanding Market Sentiment - The InvestChronicle

Les résultats de XBiotech d’une étude randomisée de phase 1/2 en double aveugle suggèrent l’émergence d’un traitement révolutionnaire potentiel contre le cancer du pancréas avancé - GlobeNewswire Inc.

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? - Benzinga

What's Going On With Small-Cap Cancer Focused XBiotech On Tuesday? By Benzinga - Investing.com UK

XBiotech Studies Find Potential Treatment for Advanced Pancreatic Cancer - MarketWatch

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for ... - Markets Insider

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for ... - GlobeNewswire

XBITXBiotech Inc. Latest Stock News & Market Updates - StockTitan

XBiotech Results from Randomized Double-Blinded Phase 1/2 Study Suggest Potential Breakthrough Treatment for Advanced Pancreatic Cancer - Yahoo Finance

XBiotech to Deliver Presentation on Novel Study Design and Phase III Results From European Study on Xilonix ... - br.ADVFN.com

XBiotech Announces Rapid Enrollment for its Randomized Multi-Center Clinical Study for Bermekimab in Patients with ... - br.ADVFN.com

Market Insight: XBiotech Inc (XBIT)'s Notable Drop, Closing at 7.37 – DWinneX - The Dwinnex

XBiotech (NASDAQ:XBIT) Shares Cross Below 50-Day Moving Average of $8.40 - MarketBeat

XBiotech (NASDAQ:XBIT) Stock Crosses Below Fifty Day Moving Average of $8.40 - Defense World

XBiotech Publishes Results in PLOS ONE for its True Human Antibody 514G3 Targeting S. aureus - Yahoo Movies UK

(XBIT) Long Term Investment Analysis - Stock Traders Daily

XBiotech: Several Shots On Goal In Big Target Market Indications (NASDAQ:XBIT) - Seeking Alpha

XBiotech Announces Successful Completion of EMA GMP Inspection - Yahoo News UK

National Bank of Canada FI Acquires Shares of 24347 XBiotech Inc. (NASDAQ:XBIT) - Defense World

XBITに似た銘柄